Analogs of PPAR-γ ligands, α-, γ-, and mixed tocopherols, are important for the inhibition of cancer in animals [17, 18, 70, 71], suggesting that γ- and δ-tocopherols should be considered as anticancerogenic nutraceutics for studies in humans. This evidence concerns the gene PPARG and cancer.